Health Canada drug identification number

DIN 02230302 — CODEINE CONTIN 50MG CONTROLLED RELEASE TAB 50 MG

CODEINE CONTIN 50MG CONTROLLED RELEASE TAB is a tablet (extended-release) of Codeine marketed by PURDUE PHARMA. The full Codeine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02230302
Brand name
CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Active ingredient
Codeine
Strength
50 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
PURDUE PHARMA
Health Canada status
MARKETED
Drug class
Opioid analgesic and antitussive

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Codeine products

DINBrandStrengthFormManufacturerStatus
02009889 CODEINE 15 15 MG TABLET LABORATOIRE RIVA INC. DORMANT
02009757 CODEINE 30 30 MG TABLET LABORATOIRE RIVA INC. MARKETED
02163748 CODEINE CONTIN 100MG CONTROLLED RELEASE TAB 100 MG TABLET (EXTENDED-RELEASE) PURDUE PHARMA MARKETED
02163780 CODEINE CONTIN 150MG CONTROLLED RELEASE TAB 150 MG TABLET (EXTENDED-RELEASE) PURDUE PHARMA MARKETED
02163799 CODEINE CONTIN 200MG CONTROLLED RELEASE TAB 200 MG TABLET (EXTENDED-RELEASE) PURDUE PHARMA MARKETED
00050024 CODEINE PHOSPHATE SYRUP 25 MG SYRUP LABORATOIRE ATLAS INC MARKETED
00380571 LINCTUS CODEINE BLANC 10 MG SOLUTION LABORATOIRE ATLAS INC MARKETED
00593435 TEVA-CODEINE 15 MG TABLET TEVA CANADA LIMITED MARKETED
00593451 TEVA-CODEINE 30 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.